D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 133 SEK -3.62% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Net Income Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Net Income
-kr58.9m
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Net Income
kr443.1m
CAGR 3-Years
25%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Net Income
kr94.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Net Income
-kr3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Net Income
kr4.2B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Net Income
kr252.6m
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Net Income?
Net Income
-58.9m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Net Income amounts to -58.9m SEK.

What is Devyser Diagnostics AB's Net Income growth rate?
Net Income CAGR 3Y
-75%

Over the last year, the Net Income growth was -13%. The average annual Net Income growth rates for Devyser Diagnostics AB have been -75% over the past three years .

Back to Top